Endurance Training Improves GLP-1 Sensitivity and Glucose Tolerance in Overweight Women
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Context and objective: Obesity and inactivity are risk factors for developing impaired glucose tolerance characterized by insulin resistance and reduced beta-cell function. The stimulatory effect of glucagon-like peptide 1 (GLP-1) on insulin secretion is also impaired in obese, inactive individuals. The aim of this study was to investigate whether endurance training influences beta-cell sensitivity to GLP-1. Participants and intervention: Twenty-four female participants, age 46 ± 2 years, body mass index 32.4 ± 0.9 kg/m2, and maximal oxygen consumption 24.7 ± 0.8 mL/kg/min participated in a 10-week exercise training study. Methods: Beta-cell sensitivity to GLP-1 was assessed in a subset of participants (n = 6) during a 120-minute hyperglycemic glucose clamp (8.5 mM) including a 1-hour GLP-1 (7-36 amide) infusion (0.4 pmol/kg/min). Changes in glucose tolerance, body composition, and cardiorespiratory fitness were assessed by oral glucose tolerance tests (OGTTs), dual-energy X-ray absorptiometry scans, magnetic resonance scans, and maximal oxygen consumption (VO2max) tests, respectively. Results: The c-peptide response to infusion of GLP-1 increased 28 ± 3% (P < 0.05) toward the end of the hyperglycemic clamp. The insulin response remained unchanged. Training improved glucose tolerance and reduced GLP-1, insulin, and glucagon levels during the OGTTs. Training increased VO2max (from 24.7 ± 0.8 to 27.0 ± 0.7 mL/kg/min; P < 0.05) and reduced visceral fat volume (from 4176 ± 265 to 3888 ± 266 cm3; P < 0.01). Conclusion: Along with improved glycemic control, endurance training improved beta-cell sensitivity to GLP-1 in overweight women. The study was deemed not to constitute a clinical trial and was not registered as such.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among the efficacious PA strategies, some authors suggested that mixed (aerobic + strength EXE) [135], continuous and intermittent endurance training [133,134], balance and mobility EXE [136] are useful to people taking AOMs.”
From Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review (2025) · cites this paper as [133]
Experimental — accuracy not yet measuredIn the citing paper
“Åkerström et al. [133] observed a positive impact of endurance training on β-cell sensitivity to GLP-1 in 24 female participants randomized into two groups: one performing 10 weeks of intermittent training (27 min) and the other performing continuous training (40 min).”
From Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review (2025) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Self-citationNauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
Self-citationKahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans
Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 919
Self-citationDeterminants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
Toft-Nielsen, M.-B., Damholt, M. B., Madsbad, S., Hilsted, L. M., Hughes, T. E., Michelsen, B. K., & Holst, J. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7750 · Cited by 869
Self-citationThe role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824 · cited 1×
“GLP-1 and GIP are released from enteroendocrine cells in response to nutrients and potentiate glucose-induced insulin secretion via activation of their specific receptors on the pancreatic beta cells [15-18].”
BackgroundPhillips, D. I. W., Clark, P. M., Hales, C. N., & Osmond, C. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00273.x · Cited by 631 · cited 2×
“The insulinogenic index was defined as the ratio of the increment of plasma c-peptide to that plasma glucose at 30 minutes after the glucose load [36, 37].”
MethodFerrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1133 · Cited by 540 · cited 1×
“Among the characteristics of the dysfunctional beta cell in type 2 diabetes and prediabetes is an attenuated incretin effect [10-14].”
BackgroundVilsbøll, T., Krarup, T., Sonne, J., Madsbad, S., Vølund, A., Juul, A. G., & Holst, J. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021873 · Cited by 528 · cited 1×
“GLP-1 and GIP are released from enteroendocrine cells in response to nutrients and potentiate glucose-induced insulin secretion via activation of their specific receptors on the pancreatic beta cells [15-18].”
BackgroundSelf-citationNauck, M. A. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.4.912 · Cited by 506
Exercise-stimulated glucose uptake — regulation and implications for glycaemic control
Sylow, L., Kleinert, M., Richter, E. A., & Jensen, T. E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.162 · Cited by 498 · cited 1×
“Although exercise training can improve peripheral insulin sensitivity [21, 22] and beta-cell function [23-25], less is known about the effects of exercise training on the secretory capacity of enteroendocrine L cells (secreting GLP-1) and K cells (secreting GIP).”
BackgroundMuscelli, E., Mari, A., Casolaro, A., Camastra, S., Seghieri, G., Gastaldelli, A., Holst, J. J., & Ferrannini, E. (2008) · Diabetes · doi:10.2337/db07-1315 · Cited by 409
Self-citationDeacon, C. F., Nauck, M. A., Meier, J., Hücking, K., & Holst, J. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6855 · Cited by 401
Self-citationRisk factors for worsening to diabetes in subjects with impaired glucose tolerance
Kadowaki, T., Miyake, Y., Hagura, R., Akanuma, Y., Kajinuma, H., Kuzuya, N., Takaku, F., & Kosaka, K. (1984) · Diabetologia · doi:10.1007/bf00252262 · Cited by 316
Metabolic Responses to Reduced Daily Steps in Healthy Nonexercising Men
(2008) · JAMA · doi:10.1001/jama.299.11.1259 · Cited by 313
Self-citationMeyer, C., Pimenta, W., Woerle, H. J., Van Haeften, T., Szoke, E., Mitrakou, A., & Gerich, J. (2006) · Diabetes Care · doi:10.2337/dc06-0438 · Cited by 308
Deacon, C. F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3575 · Cited by 301
The ten-year follow-up of the Bedford Survey (1962?1972): Glucose tolerance and diabetes
Keen, H., Jarrett, R. J., & McCartney, P. (1982) · Diabetologia · doi:10.1007/bf00254832 · Cited by 283
Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
Holst, J. J., Knop, F. K., Vilsbøll, T., Krarup, T., & Madsbad, S. (2011) · Diabetes Care · doi:10.2337/dc11-s227 · Cited by 280
Self-citationWay, K. L., Hackett, D. A., Baker, M. K., & Johnson, N. A. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.4.253 · Cited by 244
Rask, E., Olsson, T., Söderberg, S., Johnson, O., Seckl, J., Holst, J. J., & Ahrén, B. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1640 · Cited by 229
Self-citationKnop, F. K., Aaboe, K., Vilsbøll, T., Vølund, A., Holst, J. J., Krarup, T., & Madsbad, S. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01549.x · Cited by 195
Self-citationFerrannini, E., & Mingrone, G. (2009) · Diabetes Care · doi:10.2337/dc08-1762 · Cited by 194
Wareham, N. J., Byrne, C. D., Hales, C. N., & Phillips, D. I. W. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00399.x · Cited by 187
Physical training may enhance β-cell function in type 2 diabetes
Dela, F., von Linstow, M. E., Mikines, K. J., & Galbo, H. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00056.2004 · Cited by 187
Færch, K., Vaag, A. A., Holst, J. J., Glümer, C., Pedersen, O. B., & Borch‐Johnsen, K. (2008) · Diabetologia · doi:10.1007/s00125-008-0951-x · Cited by 156
Self-citationThe Liver–α-Cell Axis and Type 2 Diabetes
Wewer Albrechtsen, N. J., Pedersen, J., Galsgaard, K. D., Winther-Sørensen, M., Suppli, M. P., Janah, L., Gromada, J., Vilstrup, H., Knop, F. K., & Holst, J. J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00251 · Cited by 149
Self-citationTissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans
Ørskov, C., Rabenhøj, L., Wettergren, A., et al. (1994) · Diabetes · doi:10.2337/diabetes.43.4.535 · Cited by 143
Heiskanen, M. A., Motiani, K. K., Mari, A., Saunavaara, V., Eskelinen, J.-J., Virtanen, K. A., Koivumäki, M., Löyttyniemi, E., Nuutila, P., Kalliokoski, K. K., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4627-x · Cited by 142 · cited 1×
“Although exercise training can improve peripheral insulin sensitivity [21, 22] and beta-cell function [23-25], less is known about the effects of exercise training on the secretory capacity of enteroendocrine L cells (secreting GLP-1) and K cells (secreting GIP).”
BackgroundSolomon, T. P. J., Haus, J. M., Kelly, K. R., Rocco, M., Kashyap, S. R., & Kirwan, J. P. (2010) · Diabetes Care · doi:10.2337/dc09-2021 · Cited by 113
GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study
Ellingsgaard, H., Seelig, E., Timper, K., Coslovsky, M., Soederlund, L., Lyngbæk, M. P. P., Albrechtsen, N. J. W., Schmidt‐Trucksäss, A., Hanssen, H., Frey, W. O., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-05045-y · Cited by 105
Self-citationRask, E., Olsson, T., Söderberg, S., Holst, J. J., Tura, A., Pacini, G., & Åhrén, B. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.011 · Cited by 99
Self-citationHofsø, D., Jenssen, T., Bollerslev, J., Ueland, T., Godang, K., Stumvoll, M., Sandbu, R., Røislien, J., & Hjelmesæth, J. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0804 · Cited by 83
The Measurement of Insulin Clearance
Piccinini, F., & Bergman, R. N. (2020) · Diabetes Care · doi:10.2337/dc20-0750 · Cited by 82
King, H., Zimmet, P., Raper, L., & Balkau, B. (1984) · Diabetologia · doi:10.1007/bf00252261 · Cited by 79
Fritsche, A., Stefan, N., Hardt, E., Häring, H., & Stümvoll, M. (2000) · Diabetologia · doi:10.1007/s001250051461 · Cited by 78
Jensen, D. H., Aaboe, K., Henriksen, J. E., Vølund, A., Holst, J. J., Madsbad, S., & Krarup, T. (2012) · Diabetologia · doi:10.1007/s00125-012-2459-7 · Cited by 76
Self-citationMensberg, P., Nyby, S., Jørgensen, P. G., Storgaard, H., Jensen, M. T., Sivertsen, J., Holst, J. J., Kiens, B., Richter, E. A., Knop, F. K., et al. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12797 · Cited by 69
Self-citationβ- and α-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance
Ahrén, B. (2009) · Diabetes · doi:10.2337/db08-1158 · Cited by 68
The benefits of physical exercise for the health of the pancreatic β‐cell: a review of the evidence
Curran, M., Drayson, M. T., Andrews, R. C., Zoppi, C., Barlow, J. P., Solomon, T. P. J., & Narendran, P. (2020) · Experimental Physiology · doi:10.1113/ep088220 · Cited by 67
Larsson, H. E., & Ahr�n, B. (1996) · Diabetologia · doi:10.1007/bf00400660 · Cited by 60
Larsson, H., & Ahr�n, B. (1996) · Diabetologia · doi:10.1007/s001250050559 · Cited by 60
Ahren, B., Larsson, H., & Holst, J. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370127 · Cited by 55
Self-citationIslet dysfunction in obese women with impaired glucose tolerance
Larsson, H., & Ahrén, B. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90227-9 · Cited by 44
Quist, J. S., Blond, M. B., Gram, A. S., Steenholt, C. B., Janus, C., Holst, J. J., Rehfeld, J. F., Sjödin, A., Stallknecht, B., & Rosenkilde, M. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00239.2018 · Cited by 28
Self-citationMalin, S. K., François, M. E., Eichner, N. Z. M., Gilbertson, N. M., Heiston, E. M., Fabris, C., & Breton, M. D. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00680.2018 · Cited by 27
Janus, C., Vistisen, D., Amadid, H., Witte, D. R., Lauritzen, T., Brage, S., Bjerregaard, A., Hansen, T. F., Holst, J. J., Jørgensen, M. E., et al. (2019) · Endocrine Connections · doi:10.1530/ec-19-0408 · Cited by 24
Self-citationEffects of Acute Exercise on Pancreatic Endocrine Function in Subjects with Type 2 Diabetes
Knudsen, S. H., Karstoft, K., Winding, K., Holst, J. J., Pedersen, B. K., & Solomon, T. P. J. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12413 · Cited by 15 · cited 2×
“Some studies have shown that exercise-induced improvements of beta-cell function in patients with type 2 diabetes are influenced by the diabetic status [23, 40]; thus, some patients may only benefit from exercise if exercise is combined with pharmacological treatment.”
BackgroundSelf-citation(1960) · PubMed
Cited by
Exercise Induces Tissue-Specific Adaptations to Enhance Cardiometabolic Health
Ashcroft, S. P., Stocks, B., Egan, B., & Zierath, J. R. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.008 · Cited by 149
Ingersen, A., Schmücker, M., Alexandersen, C., Graungaard, B., Thorngreen, T., Borch, J., Holst, J. J., Helge, J. W., & Dela, F. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad326 · Cited by 39
Self-citationJin, Z., Li, J., Thackray, A. E., Shen, T., Deighton, K., King, J. A., & Stensel, D. J. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01726-4 · Cited by 20
“18 non-RCTs [11, 63 – 65, 69, 70, 73, 74, 76, 86, 91, 93, 96, 103, 109, 153, 161, 164] were included, with 27 independent and 2 cross-over intervention groups (24 CR and 5 EX groups), involving 757 participants.”
Barana, L., De Fano, M., Cavallo, M., Manco, M., Prete, D., Fanelli, C. G., Porcellati, F., & Pippi, R. (2025) · Nutrients · doi:10.3390/nu18010131 · Cited by 13
Pharmacogenetics of Glucagon-like-peptide-1 receptor in diabetes management
Kalinkova, M., Kadiyska, T., & Handjieva‐Darlenska, T. (2023) · Pharmacia · doi:10.3897/pharmacia.70.e104481 · Cited by 6
Metadata
- Authors
- Åkerström, T., Stolpe, M. N., Widmer, R., Dejgaard, T. F., Højberg, J. M., Møller, K., Hansen, J. S., Trinh, B., Holst, J. J., Thomsen, C., Pedersen, B. K., & Ellingsgaard, H.
- Affiliations
- Centre of Inflammation and Metabolism and Centre for Physical Activity Research, Rigshospitalet, Copenhagen University Hospital – Rigshospitalet , DK 2100 Copenhagen , Denmark
- University of Copenhagen (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Novo Nordisk (Denmark) (DK)
- Corresponding author
- Ellingsgaard, Helga
- ORCID
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2022-07-26
- Volume
- 6
- Issue
- 9
- Pages
- bvac111-bvac111
- ISSN
- 2472-1972 (ISSN-L)
- PMC
- PMC9351379
- OpenAlex
- W4288036583
- Cited by
- 15
- References
- 51
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 1 · 2023: 4
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the Endocrine Society (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
- Funders
- Centre for Physical Activity Research
- TrygFonden (ID 101390, ID 20045, ID 125132)
- Centre of Inflammation and Metabolism
- Danish National Research Foundation (#02-512-55)
- Commission of the European Communities (LSHM-CT-2004-005272)
- Danish Medical Research Council
- Carla Thiel Kragh Foundation
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- endurance training, glucagon-like peptide-1, glucose tolerance, overweight women, obesity, insulin resistance, C-peptide response, visceral fat, cardiorespiratory fitness, oral glucose tolerance test
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.